What past blockbusters tell us about Wegovy's future; the impossibility of being a mom in American medicine

We can't know what the future will look like for weight loss drugs. But in medicine, history doesn't repeat but it does rhyme.

August 24, 2023 Check out STAT+

Sponsored By

AP Photo/Morry Gash Republican presidential candidates spar over abortion bans Republican presidential candidates sparred over a controversial question: Now that abortion bans are possible, how far should they go? By Sarah Owermohle and Lizzy Lawrence STAT+ | What past blockbusters can tell us about future of Wegovy and other weight loss medicines Looking at other blockbuster drugs — their successes and failures — is a pretty good guide as to what could happen next. By Matthew Herper STAT+ | Mid-year drug price hikes are back despite Inflation Reduction Act Last month, drugmakers raised wholesale prices of over 123 drugs, by up to 10% for some, marking the largest number of mid-year price hikes since 2013. By Simar Bajaj Mike Reddy for STAT Krystal Cascetta, Lindsay Clancy, and the impossibility of being a mom in American medicine Being an American mother is hard. Being an American mother in medicine can feel untenable, as I have learned. By Jennifer Adaeze Okwerekwu STAT+ | Drugmakers already bet big on mRNA for cancer. Why is Biden going in, too? Drugmakers already bet big on mRNA for cancer. So why is Biden's new health agency, ARPA-H, going in, too? By Damian Garde and Sarah Owermohle Opinion: How to save the U.S. News & World Report Best Hospitals rankings Now is the time for health care ratings to offer patients transparent and useful measures of quality that enable informed choices. By Brian Stein and Bala Hota Listen: Vivek's star turn, leaky drug data, & biotech as family business We discuss how Vivek Ramaswamy, fresh off his GOP debate debut, went from a drug industry entrepreneur to the party's rising star. By Damian Garde and Allison DeAngelis and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser